AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H971-H978, 2004. First published November 26, 2003; doi:10.1152/ajpheart.00308.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
286/3/H971    most recent
00308.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escobar, A. L.
Right arrow Articles by Mejía-Alvarez, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escobar, A. L.
Right arrow Articles by Mejía-Alvarez, R.

Developmental changes of intracellular Ca2+ transients in beating rat hearts

Ariel L. Escobar,1 Roberta Ribeiro-Costa,1 Carlos Villalba-Galea,1 María Elena Zoghbi,1 Claudia G. Pérez,2 and Rafael Mejía-Alvarez2

1Department of Physiology, Health Sciences Center, Texas Tech University, Lubbock, Texas 79430; and 2Department of Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinios 60153

Submitted 3 April 2003 ; accepted in final form 7 November 2003


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Postnatal maturation of the rat heart is characterized by major changes in the mechanism of excitation-contraction (E-C) coupling. In the neonate, the t tubules and sarcoplasmic reticulum (SR) are not fully developed yet. Consequently, Ca2+-induced Ca2+ release (CICR) does not play a central role in E-C coupling. In the neonate, most of the Ca2+ that triggers contraction comes through the sarcolemma. In this work, we defined the contribution of the sarcolemmal Ca2+ entry and the Ca2+ released from the SR to the Ca2+ transient during the first 3 wk of postnatal development. To this end, intracellular Ca2+ transients were measured in whole hearts from neonate rats by using the pulsed local field fluorescence technique. To estimate the contribution of each Ca2+ flux to the global intracellular Ca2+ transient, different pharmacological agents were used. Ryanodine was applied to evaluate ryanodine receptor-mediated Ca2+ release from the SR, nifedipine for dihydropyridine-sensitive L-type Ca2+ current, Ni2+ for the current resulting from the reverse-mode Na+/Ca2+ exchange, and mibefradil for the T-type Ca2+ current. Our results showed that the relative contribution of each Ca2+ flux changes considerably during the first 3 wk of postnatal development. Early after birth (1–5 days), the sarcolemmal Ca2+ flux predominates, whereas at 3 wk of age, CICR from the SR is the most important. This transition may reflect the progressive development of the t tube-SR units characteristic of mature myocytes. We have hence directly defined in the whole beating heart the developmental changes of E-C coupling previously evaluated in single (acutely isolated or cultured) cells and multicellular preparations.

neonate; ryanodine receptor; cardiac excitation-contraction coupling; intact heart


IN CARDIAC MYOCYTES, the action potential (AP) opens voltage-sensitive L-type Ca2+ channels located in the t tube and the surface membrane. The resulting Ca2+ influx activates ryanodine receptors (RyR) situated in the junctional sarcoplasmic reticulum (SR), leading to a large SR Ca2+ release that ultimately triggers contraction. This process, known as Ca2+-induced Ca2+ release (CICR), is the predominant mechanism of excitation-coupling (E-C) coupling in adult rat hearts. Before birth, however, CICR appears to be absent, becoming evident after few days of postnatal life (1, 12, 25). Yet, at the neonatal age, CICR is less dominant than it is in the adult. The general notion is that contractile activation during early neonatal stages remains largely dependent on sarcolemmal Ca2+ influx. This Ca2+ flux is mediated by several channels and transporters that include L-type Ca2+ channels (3, 7, 12, 27), T-type Ca2+ channels (13, 29), other dihydropyridines (DHP)-resistant Ca2+ channels (26), and by the Na+/Ca2+ exchanger operating in reverse mode (16, 24). The still prominent plateau of the AP at this stage reflects the relative importance of this sarcolemmal Ca2+ influx as the primary mechanism of E-C coupling. As the cell matures, contractile activation becomes progressively more dependent on CICR, and therefore the AP plateau becomes less apparent. In the rat, this AP shortening is considerably more evident, and it continues throughout the postnatal development until the plateau virtually disappears due to the presence of large transient depolarizing currents (i.e., Ito).

Although it is clear that CICR is not the predominant mechanism of E-C coupling in the neonatal myocardium, several lines of evidence suggest that RyR-mediated SR Ca2+ release might play a substantial role, even at early stages of postnatal development. For example, it has been reported that during the first day of postnatal life, ryanodine (0.1–1 µM) decreases the systolic tension up to ~50% in multicellular preparations (1, 16, 25, 28). In cultured neonate myocytes, ryanodine (0.1 µM) reduced ~25% of the amplitude of intra-cellular Ca2+ transients triggered by APs (12). In the same preparation, ryanodine (10 µM) completely abolished spontaneous local Ca2+ release events as well (14). Furthermore, the robust response to caffeine reported in acutely isolated ventricular myocytes from the neonate rabbit (9) suggests a more important role of RyRs.

An additional source of uncertainty about the functional role of RyR in the neonate heart is that most of the information concerning the development of cardiac E-C coupling has been derived from studies conducted either on primary cultures or, in few cases, on acutely isolated cells. Although very valuable in nature, these experimental models pose the challenge of extrapolating the results to intact cells and to the whole organ working under physiological conditions. Factors that exist in the whole heart (e.g., cell-to-cell interactions, intact extracellular matrix, etc.) are either disturbed (mechanically or enzymatically) or simply not present in cellular models. To circumvent those obstacles, we have applied in this work the pulsed local-field fluorescence technique (5) to quantitatively define the developmental changes of the Ca2+ transients with cellular resolution but recorded in the beating whole heart (6, 15). With this approach, we have estimated how the contribution of each Ca2+ flux to the global intracellular Ca2+ transient changes during the first 3 wk of postnatal life. Specifically, we evaluated RyR-mediated SR Ca2+ release, L-type Ca2+ current, T-type Ca2+ current, and the Ca2+ current resulting from the reverse-mode operation of the Na+/Ca2+ exchanger. Furthermore, we have studied the developmental changes of the cardiac E-C coupling mechanism under experimental conditions that closely resemble those found in vivo. These conditions included the intact heart, coronary perfusion, 37°C, and spontaneous contractile activity.

Preliminary versions of this work have been previously presented at the Biophysical Society Annual Meeting (5, 6) and Iberoamerican Congress of Biophysics.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Whole heart preparation. Neonate (1–5 days old) and juvenile (3 wk old) Wistar rats of either sex were used in this study. Rats were injected intraperitoneally with a mixture of heparin sodium (180 U/kg; Elkins-Sinn, Cherry Hill, NJ) and a low dose of pentobarbital sodium (50 µg/100 g of weight; Abbott) to induce mild sedation. After 10 min, the rat was euthanized by cervical dislocation in accordance with Institutional Animal Care and Use Committee guidelines. The whole heart preparation for pulsed local-field fluorescence detection was setup as previously described (15). Briefly, the heart was removed by a thoracotomy and washed out at room temperature with normal Tyrode solution (in mM: 140 NaCl, 5 KCl, 2 CaCl2, 1.2 KH2PO4, 1 MgCl2, 20 glucose, and 10 HEPES-K; pH = 7.4). The aorta was cannulated and connected to a standard Langendorff apparatus to continuously perfuse the heart with normal Tyrode solution at a rate of 1 ml/min. External pacing was employed only when the pacemaker activity was modified to a large extent by pharmacological agents like ryanodine and nifedipine. In those cases, current pulses of 3 mA and 1–3 ms were applied through platinum electrodes immersed into the bath at a frequency of 2 Hz. To measure changes of intracellular free [Ca2+], myocardial cells were loaded with the acetoxymethyl ester form (AM) of the Ca2+-sensitive fluorescent indicator Rhod-2 (Molecular Probes; Eugene, OR). Rhod-2 was dissolved in 4% pluronic F-127 dimethyl sulfoxide solution and then diluted in normal Tyrode to a final concentration of 30 µM. The hearts were perfused with dye-containing Tyrode solution for a period that ranged between 30 and 45 min. Only those hearts that maintained vigorous and regular contractility throughout the incubation period were used for fluorescence detections. All the experiments were conducted at 37°C, and normal Tyrode solution was perfused throughout the whole experiment.

Whole heart fluorescence measurements. Fluorescence signals were recorded in perfused beating hearts by using the pulsed local field fluorescence detection technique as previously described (15). Briefly, a small (200 µm core diameter) multimode fiberoptic (3M) was used to simultaneously excite the fluorophore and collect the emitted fluorescence. A frequency-doubled, nanogreen-pulsed Nd-YAG laser (JDS Uniphase NanoLaser) was used to illuminate the tissue with short pulses (0.9 ns) of light (532 nm wavelength) at a frequency of 12 kHz. To eliminate motion artifacts associated with the contraction, the tip of the fiberoptic was inserted into a small patch-clamp glass pipette onto which gentle suction was applied. The negative pressure stabilized the tip of the fiberoptic against the moving wall of the heart. To record the fluorescence from specific regions of the heart, the tip of the fiberoptic was positioned and held in place with the aid of a micromanipulator. Emitted fluorescence was carried back through the same fiberoptic, filtered, and focused on an avalanche photodiode (EG & G) that was connected to a variable bandwidth (3.8–125 GHz) current-to-voltage converter. The voltage output of the photodiode was digitized with an analog-to-digital converter (PCI 6110, National Instruments) at a sampling frequency of 500 kHz and a bandwidth of 125 kHz. The fluorescence envelope trace was obtained offline as previously described (15) at a frequency of 12 kHz. Briefly, the peak of each fluorescence transient elicited with 0.9-ns light pulses was determined and stored in a separate file. Because only the amplitude of rhod-2 fluorescence transient depends on [Ca2+], the estimation of its maximal value allowed us to continuously monitor how the intracellular [Ca2+] changed over time. Pooled data are presented as means ± SE. Statistical significance in Figs. 3 and 5 and Table 1 was determined with two-tail P values obtained from unpaired t-tests.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3. Ni2+-sensitive component of the Ca2+ transient in neonate hearts. A: Ca2+ transients recorded from the left ventricle in 1-day-old rat, during sequential exposition to ryanodine (100 µM), nifedipine (10 µM), and Ni2+ (2 mM). B: averaged traces (from 30 individual traces) illustrating the kinetic attributes time to peak (tpeak) and time constant decay ({tau}decay) of the Ca2+ transient recorded under each condition at 2 Hz of external pacing. Averaged Ca2+ transient in the Ni2+ condition was constructed from the events recorded after the Ni2+ effect was established (arrow). Vertical dashed lines indicate the tpeak. Curves are single exponential functions fitted to the decaying phase. Kinetic parameters under different conditions had the following values: control, tpeak = 44 ms and {tau}decay = 66 ms; ryanodine, tpeak = 51 ms and {tau}decay = 68 ms; nifedipine, tpeak = 53 ms and {tau}decay = 156 ms; Ni2+, tpeak = 134 ms and {tau}decay = 420 ms. B: mean values ± SE of Ca2+ transient amplitude as percentage of control after perfusing the indicated pharmacological agents at 1–3 and 21 days. Transient amplitudes in neonate were 89.5 ± 8%, 44.2 ± 5.5%, and 6.8 ± 9.5% after ryanodine, nifedipine, and Ni2+, respectively (n = 4), whereas in juvenile hearts the amplitudes were 26.8 ± 8%, 4 ± 4%, and 65 ± 4% with ryanodine, nifedipine, or Ni2+, respectively (n = 5). *Statistical difference (P < 0.005).

 


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5. Mibefradil-sensitive component of Ca2+ transient in neonate heart. A: Ca2+ transients (top) recorded from left ventricle in 1-day-old rat at 2 Hz of external pacing during sequential exposition to ryanodine (100 µM), nifedipine (10 µM), and mibefradil (1.8 µM). Bottom, averaged traces (from 30 individual traces) illustrating the kinetic properties (tpeak and {tau}decay) of the Ca2+ transient recorded under each condition. Dashed lines indicate the tpeak. Curves are single exponential functions fitted to the decaying phase. Kinetic parameters under different conditions had the following values: control, tpeak = 50 ms and {tau}decay = 120 ms; ryanodine, tpeak = 57 ms and {tau}decay = 122 ms; nifedipine, tpeak = 60 ms and {tau}decay = 83 ms; mibefradil, tpeak = 68 ms and {tau}decay = 137 ms; washout tpeak = 80 ms and {tau}decay 270 ms. B: mean values ± SE of Ca2+ transient amplitude as a percentage of control, after perfusing the indicated pharmacological agents at 1–3 and 21 days. Transient amplitudes in neonate were 88.5 ± 10%, 60 ± 14.5%, and 25 ± 9.5%, after ryanodine, nifedipine, and mibefradil, respectively (n = 4), whereas in juvenile the amplitudes were 25.2 ± 9%, 7 ± 6%, and 84.2 ± 13.2% with ryanodine, nifedipine, or mibefradil, respectively (n = 4). *Statistical difference (P < 0.005).

 

View this table:
[in this window]
[in a new window]
 
Table 1. Developmental changes of Ca2+ transient kinetics

 

Ventricular myocytes isolation. Ventricular myocytes were enzymatically isolated from both neonate (1 day old) and juvenile (3 wk old) rat hearts by using the standard Langendorff technique. Briefly, isolated hearts were rinsed in normal Tyrode solution (composition in mM: 140 NaCl, 5 KCl, 2 CaCl2, 1.2 KH2PO4, 1 MgCl2, 20 glucose, and 10 HEPES-K; pH = 7.4). The aorta was cannulated, and the heart was mounted in a Langendorff perfusion apparatus. Flow rates varied accordingly to the rat's age: 1 ml/min for neonates and 3 ml/min for juvenile rats. Nominally Ca2+-free Tyrode solution was perfused for variable times depending on the animal's age between 3 min (neonate) and 6 min (juvenile). Enzymatic digestion of the myocardium was carried out by perfusing a mixture of collagenase (0.5 mg/ml, II, Worthington Biochem; Lakewood, NJ) and protease (0.05 mg /ml, XIV, Sigma-Aldrich; St. Louis, MO) dissolved in a low-Ca2+ (200 µM) Tyrode solution during 10 min for both neonate and juvenile hearts. Enzyme was washed out for 6 min with low-Ca2+ (200 µM) Tyrode solution, followed by a 3-min period with normal Tyrode solution. Ventricles were cut and minced. Single myocytes were obtained by gentle dispersion with a wide-bore pipette and filtering through cotton gauze. Isolated cells were placed in normal Tyrode and kept at room temperature (23°C) until used. All the solutions used for heart perfusion were at 37°C.

Single cell fluorescence measurements. Single myocytes were loaded with a fluorescent indicator by incubating the cells in 2 µM rhod-2 AM (Molecular Probes) at room temperature (23°C). Optimal loading levels were obtained when the incubation time was ~30 min for adult and ~45 min for neonate cells. Longer incubation times were deleterious for the cells. The incubation period was ended by rinsing the cells during 15 min with dye-free normal Tyrode solution at 23°C. Loaded myocytes were then placed on the stage of an inverted fluorescence microscope (Nikon, Diaphot) modified for flash laser imaging (4). AP-stimulated Ca2+ transients were recorded in normal Tyrode solution at 23°C. The use of higher temperatures (i.e., 37°C) normally yielded unexcitable cells. APs were triggered by field stimulation with platinum electrodes placed in the experimental chamber. Intracellular [Ca2+] was evaluated by epifluorescence detection on single ventricular myocytes from neonate and juvenile rat hearts. Fluorescence signal was digitized at a rate of 2 kHz with a 32-bit AD/DA converter and controlled by Labview-based software (National Instruments; Austin, TX) and a Pentium II-based personal computer. Results are expressed as relative fluorescence intensity.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Ryanodine effect in acutely isolated myocytes. To evaluate the developmental changes of the RyR-mediated component of the Ca2+ transient, the effects of ryanodine were explored in juvenile and 1-day-old neonate rats. Acutely isolated myocytes were preferred over cultured cells to avoid possible culture-related factors that could affect the response of RyRs to the incoming triggering Ca2+ wave. Figure 1 shows that ryanodine blocked ~75% of the transient in the juvenile rat, whereas in the neonate rat the effect of large concentrations of ryanodine (100 µM) was negligible, if any. In addition, the temporal course of the Ca2+ transient in the neonate rat before and after ryanodine was considerably slower than in the juvenile rat. Time to peak, for instance, was 240 ms, whereas in the juvenile rat it was 54 ms. The possibility that nonspecific damage secondary to the isolation procedure was the cause of such a slow temporal course of the Ca2+ transient and of the absence of CICR could not be ruled out. Because we were interested in evaluating the participation of RyRs under experimental conditions where the E-C coupling machinery remains intact, we decided to conduct our studies in intact whole hearts by using the pulsed local field fluorescence detection technique.



View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1. Ryanodine effect in freshly isolated myocytes from juvenile and neonate rat hearts. Ca2+ transients recorded in rhod-2-loaded ventricular myocytes, acutely isolated from juvenile (A) and 2-day-old neonate (B) rat hearts. Ca2+ transients were recorded at 23°C, before (gray line) and after (black line) addition of 100 µM ryanodine to the bath solution. a.u., arbitrary units.

 

RyR-mediated Ca2+ release. Figure 2A illustrates the effects of ryanodine on Ca2+ transients recorded in a spontaneously beating heart from a juvenile rat. Before the addition of ryanodine, stable and regular Ca2+ transients were recorded over a period of 20 min. A few beats after the addition of ryanodine (100 µM), however, several changes in cardiac activity were observed. First, the heart rate assessed by the Ca2+ transient frequency was reduced to ~50% of its original value (from 180 ± 22 to 90 ± 35 beats/min; P < 0.005; n = 3). Second, the interval between Ca2+ transients started to exhibit variable durations, indicating an alteration of the normal sinus rhythm. Finally, the most obvious effect of ryanodine was on the amplitude of the Ca2+ transient. The amplitude of the transient was rapidly reduced until it reached a stationary value, where it stayed for variable periods before dying out. This stationary state was usually reached after ~1 min of the drug application. Although the transient amplitude was reduced by 88% in the presence of ryanodine, the Ca2+ transient kinetics (rising and the decaying phase) were not appreciably affected.



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2. Developmental changes in the ryanodine effect. Continuous recording of rhod-2 fluorescence obtained from left ventricle spontaneous activity, before and after exposition to 100 µM ryanodine in juvenile (A) and neonate (B) rats. Arrows indicate the estimated moment at which ryanodine reached the coronary arteries. C: stationary activity under control conditions illustrates the nonspecific decay of the Ca2+ transient amplitude. After 40 min of continuous pacing at 0.75 Hz, the transient amplitude was reduced ~13% (from 8.9 to 7.7 a.u.).

 

Figure 2B shows a similar experiment conducted on a 5-day-old neonate rat heart. Unlike the juvenile rat heart, the effect of the same ryanodine concentration (100 µM) on the Ca2+ transient amplitude from the neonate rat was considerably smaller. Ryanodine induced only a 32% reduction of the amplitude without substantial changes of its temporal attributes. Additionally, ryanodine affected the pacemaker activity in a similar way than in the juvenile rat. This was indicated by a 20% reduction of the heart rate (from 126 ± 7 to 103 ± 7 beats/min; P < 0.05; n = 4). Interestingly, however, the extent of the heart rate reduction in neonate was ~30% less than in juvenile hearts.

To define how much impact nonspecific fluorescence decay would have on the Ca2+ transient amplitude, paced activity at 0.75 Hz was recorded over prolonged periods of time. Figure 2C shows that after 40 min of continuous recording, the amplitude of Ca2+ transients was only reduced ~13%. Thus loss of fluorescence had minimal impact on the ryanodine (and other agents) effects observed over considerably shorter periods of time (5–10 min).

Sarcolemmal Ca2+ entry. To define the specific contribution of the sarcolemmal Ca2+ entry to the intracellular Ca2+ transient in the neonate and juvenile stages, the effects of different pharmacological agents on the properties of the Ca2+ transient were investigated. The purpose of this strategy was to sequentially block each of the pathways through which Ca2+ ions cross the sarcolemma into the cell, namely L- and T-type Ca2+ channels and Na+/Ca2+ exchanger operating in the reverse mode. Figure 3 shows the different components of the intra-cellular Ca2+ transient in the neonate heart. The experiment shown in Fig. 3 was conducted in a heart from a 1-day-old neonate rat, and cardiac activity was externally paced at 2 Hz. Addition of ryanodine (100 µM) induced a 10.4% reduction of the Ca2+ transient amplitude without inducing substantial changes of its temporal attributes [i.e., time to peak (tpeak) and rate of decay]. This is better observed in the averaged traces shown underneath. Subsequent addition of nifedipine (10 µM) reduced ~50% of the remaining Ca2+ transient amplitude (to ~45% of the control value). The temporal properties of the Ca2+ transient after nifedipine are illustrated in the third trace of the bottom panel. Unlike the rising phase that remained essentially unchanged, the decay of the transient became slower, as indicated by the increase of the time constant decay ({tau}decay). Finally, addition of 2 mM Ni2+ blocked almost the entire transient (to ~5% of the control value), suggesting that both T-type Ca2+ channels and the Na+/Ca2+ exchanger contributed in an unknown extent to this last fraction (~35% of the whole transient). Because of the large size of the ryanodine- and nifedipine-sensitive Ca2+ fluxes in the juvenile rat hearts, the addition of the drugs could not be conducted with a sequential protocol. Instead, the effects of each drug were evaluated separately (light bars, Fig. 3B).

In an attempt to separate the contribution of T-type Ca2+ channels from the Na+/Ca2+ exchanger to the total intracellular Ca2+ transient in the neonate, the effects of different concentrations of Ni2+ were investigated. Because Ni2+ also blocks L-type Ca2+ channels (11), Ni2+ effects on Ca2+ transients were explored in the presence of nifedipine. Saturating concentrations of nifedipine (10 µM) were used to compensate for the lack of control of the resting membrane potential in the whole heart preparation. This precaution was taken because of the well-known voltage dependence of nifedipine action (2). The results of these experiments are illustrated in Fig. 4. Addition of Ni2+ reduced the amplitude of the nifedipine-resistant component of the Ca2+ transient in a dose-dependent manner. High concentrations of Ni2+ (1 mM) induced a large reduction of the Ca2+ transient, but it was readily reversed after Ni2+ was washed out (Fig. 4A, dotted trace). The temporal attributes of the Ca2+ transient, however, were not visibly changed even when Ni2+ concentrations were in the millimolar range. The dose-response relationship shown in Fig. 4B revealed an apparent Ni2+ affinity of ~220 µM and a Hill coefficient of ~1. Because of the lack of specificity, this behavior could represent a combined effect of Ni2+ on the Na+/Ca2+ exchanger operating in reverse mode and on the T-type Ca2+ channels. This is graphically illustrated in Fig. 4B, where previously published data of Ni2+ effect on the Na+/Ca2+ exchanger (10; Fig. 4B, dashed line) and on T-type Ca2+ current (13; Fig. 4B, dotted line) are shown for comparison.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4. Ni2+ effect on Ca2+ transient amplitude from neonate heart. A: averaged traces (from 20 individual traces) illustrating the effect of different concentrations of Ni2+ on the Ca2+ transient amplitude in the presence of nifedipine. B: log dose-response curve of Ni2+ on Ca2+ transient amplitude in the presence of 10 µM nifedipine. Experimental data (open circles, n = 3) were fitted (continuous line) with a Langmuir function (IC50 = 221 ± 18 µM and h = 0.9). For comparison, Ni2+ effect on Na+/Ca2+ exchanger [from Hinde et al. (10); dashed line; IC50 = 237 µM and h = 0.8] and on T-type Ca2+ current [from Leuranguer et al. (13); dotted line; IC50 = 160 µM] is included.

 

To specifically determine the contribution of the T-type Ca2+ channel to the total intracellular Ca2+ transient, the selective T-type Ca2+ channel blocker mibefradil was used. Figure 5A shows a representative experiment in which the contribution of each Ca2+ flux to the intracellular Ca2+ transient was investigated by the sequential addition of different pharmacological agents. The experiment shown in Fig. 5 was conducted in a heart from a 2-day-old neonate rat, and cardiac activity was externally paced at 2 Hz. Addition of ryanodine (100 µM) induced a reduction of the Ca2+ transient amplitude of 12.5% without inducing significant changes of its temporal attributes. Subsequent addition of nifedipine (10 µM) reduced ~32% of the remaining Ca2+ transient amplitude (to ~60% of the control value). Finally, addition of 1.8 µM mibefradil blocked to ~25% of the control value. Washout partially reversed the blockade induced by mibefradil. Ryanodine and nifedipine effects were usually irreversible. Pooled data from neonate and juvenile rats are shown in Fig. 5B. As in Fig. 3B, the effects of each drug in juvenile rats were evaluated separately.

Ca2+ transient kinetics. To correlate the developmental changes of the AP with the intracellular Ca2+ signaling, the temporal attributes of the Ca2+ transients were determined at the same ages. Figure 6 and Table 1 show how the time course of the intracellular Ca2+ transient changed during the first 3 wk of postnatal life. In Fig. 6, top, Ca2+ transients from the right atrium, right ventricle, and left ventricle recorded in 1-day-old rats are shown, whereas in Fig. 6, bottom, Ca2+ transients recorded from the same regions in a juvenile heart are illustrated. The rising phase of the Ca2+ transient accelerated with development, as indicated by the reduction of the time to peak to almost half of the value seen in the neonate. This acceleration was more evident in the ventricle. As illustrated in Fig. 6, the onset of the Ca2+ transient recorded from atrium showed modest variations with development. Interestingly, the temporal attributes of the decaying phase of the transient in both the atrium and ventricle did not show significant variations with development.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6. Developmental changes of the Ca2+ transient kinetics. Kinetic parameters (tpeak and {tau}decay) of Ca2+ transients measured in averaged traces (at least 20 individual traces). Rhod-2 fluorescence was recorded from the indicated regions of the heart at different ages. Dotted lines illustrate tpeak and the smooth curves represent monoexponential fits to the decaying phase of the transients, with r2 values that ranged between 0.94 and 0.99.

 


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The main goals of this work were to quantify the specific contribution of each Ca2+ flux to the global intracellular Ca2+ transient in the intact rat heart and to define how those fluxes change after few weeks of postnatal development. Our results indicate that the specific contribution of RyR-mediated SR Ca2+ release to the global intracellular Ca2+ transient changes rapidly during the first 3 wk of postnatal life. At birth, RyR-mediated Ca2+ release is not >15%, whereas at 3 wk of age, this component already accounts for as much as 88% of the total intracellular Ca2+ transient. This rapid transition necessarily implies a drastic modification in the mechanism of E-C coupling, from sarcolemmal Ca2+ dependent at birth, to CICR dependent at 3 wk of age. These changes in E-C coupling in turn must reflect extensive modifications of intracellular ultrastructure and architecture (17, 18). The appearance of T-tubular system that occurs at 10 days of postnatal life (17) and the emergence of a functional SR are maturational requirements for a more sophisticated and complex E-C coupling mechanism such as CICR.

Ca2+ transients in whole heart as opposed to single cells. Acutely isolated myocytes and primary cultures have been experimental models typically used for developmental studies of E-C coupling (9, 12, 14). These models, however, present a number of inconveniences that hinder a precise quantification of the Ca2+ flux that results from CICR. Examples of those problems include structural damage (particularly of the sarcolemma and/or extracellular matrix), alterations in the cell shape, and modifications of the natural differentiation pattern. The slow transient kinetics in neonate myocytes presented in Fig. 1 would be consistent with the possibility of cellular damage. This retardation was substantially larger than the one predicted from the difference in the temperature at which the experiments were conducted (23°C in single cells vs. 37°C in the whole heart). Pérez et al. (19) have recently found that the Q10 of the Ca2+ transient activation in the neonate is 2.4. Such temperature dependence would yield a time to peak of 100 ms, which is still approximately twofold slower than our measurements in the intact heart. It is possible, therefore, that enzymatically isolated neonate myocytes undergo some level of damage that could slow down the Ca2+ transient kinetics. The alternative single-cell model, primary culture, has the potential to affect CICR due to changes in relative RyR location secondary to changes of cellular shape during culture. In this regard, we have recently reported an evident exaggeration of the RyR participation in E-C coupling in primary cultures (22, 23). If the location of RyRs changes, they can become more or less responsive to activating Ca2+ because the distance to sarcolemmal Ca2+ sources (Ca2+ channels and Na+/Ca2+ exchanger) would change. To avoid all these factors, we decided to conduct our studies in intact whole hearts using the pulsed local-field fluorescence detection technique.

RyR-mediated Ca2+ release. A noticeable role of neonate RyRs has been implicated in numerous works conducted in a variety of experimental models, including multicellular preparations (1, 16, 25, 28), primary cultures (12, 14), and freshly isolated myocytes (9). Those studies have suggested based on the use of either ryanodine or caffeine, that the participation of RyRs in E-C coupling is sizeable in the neonate heart. Further support to the importance of RyRs has derived from studies of molecular biology that have demonstrated the presence of cardiac-specific RyR isoform (RyR2) mRNA in immature hearts, even as early as embryonic days 9–10 (8). Although the significance of such an early expression of RyRs is poorly understood, it is intriguing that the heart starts beating at the embryonic day 9 in the rat (gestation time of 21 days), Consequently, the possibility that RyRs could play a role, albeit minor, in E-C coupling at those embryonic stages cannot be ruled out. An additional piece of evidence on this regard stems out from a study conducted in hearts from 3-day-old neonate rabbits by Sedarat et al. (21). Those authors reported that in the neonate, ~60% of the dihydropyridine receptors (DHPRs) are already colocalized with RyRs in the periphery of the cell. Because the relative position and localization of the DHPRs and RyRs are important factors to determine the extent of CICR, this observation would imply a robust RyR-mediated Ca2+ flux during E-C coupling in the neonate. This implication would be possible only if the functional properties (i.e., unitary conductance, gating kinetics, and Ca2+ dependence) of neonate RyR were similar to the adult. Taken together, all these antecedents support the notion that the functional role of RyR in the neonate heart is important. Although our results confirmed the existence of a sizeable RyR-mediated Ca2+ flux in the intact beating whole heart from a neonate rat, they also demonstrated that the contribution of this component to the global Ca2+ transient and therefore to E-C coupling (Figs. 2, 3, and 5) is considerably smaller than previously suggested.

Another support of our conclusion derives from the temporal attributes of the Ca2+ transient. In the adult, the positive feedback nature of CICR through RyRs is evident in the rapid kinetics of the Ca2+ transient rising phase. Our results clearly reveal an acceleration of the activation phase of the ventricular Ca2+ transient with development. The results shown in Fig. 6 illustrate this phenomenon as an abbreviation of the time to peak in juvenile hearts to almost half of the value seen in the neonate. This is consistent with CICR becoming progressively more important in elevating the intracellular Ca2+ concentration. Nevertheless, changes in the distribution of L-type Ca2+ channels that have been reported to occur (21) could also induce considerable changes in the kinetics of Ca2+ release. Our experimental approach did not allow us to exclude this possibility.

Our whole heart experiments showed another important role of RyR-mediated Ca2+ flux in the immature heart, pacemaker potential. The ryanodine effect on the cardiac rhythm and frequency observed in our study, particularly in juvenile rats (Fig. 2), is consistent with the functional role of the RyR in pacemaker activity. In nodal cells from the adult cat, the RyR-mediated Ca2+ release is large enough to drive the Na+/Ca2+ exchange in the forward mode (20, 30). This inward current provides a depolarizing force during the last third of the diastole to bring the membrane potential to the activation threshold of the L-type Ca2+ current responsible for the AP upstroke. Our results indicate that this mechanism could exist in rats as well. Nevertheless, the extent of this effect in the neonate was ~30% smaller than in juvenile rats. Such a difference could suggest that the extent of RyR contribution to diastolic depolarization also changes during development. Whether this transformation results from developmental changes of density, location, and functional properties of RyR or from a combination of these factors was beyond the scope of this work.

Sarcolemmal Ca2+ entry. Another important conclusion from our results (Figs. 3, 4, 5) is that the relative size of each sarcolemmal Ca2+ flux changes during the first 3 wk of postnatal life. In the neonate, sarcolemmal Ca2+ flows almost equally through T- and L-type Ca2+ channels and through the Na+/Ca2+ exchanger. Our pooled data from four hearts shown in Fig. 5B indicate that the contribution to the Ca2+ transient of each of these paths is roughly ~30%. In juvenile rats, however, sarcolemmal Ca2+ entry occurs predominantly through the DHP-sensitive L-type Ca2+ channel as it is indicated by the large effect of nifedipine and the rather modest reduction induced by mibefradil. Such a large effect of nifedipine should result from the combined effects on the L-type Ca2+ channel directly and from the inability to induce RyR-mediated Ca2+ release from the SR. Consequently, the amplitude difference between the experiment with ryanodine and with nifedipine is a good estimate of the component mediated by L-type Ca2+ channels. This component in the neonate accounts for ~35% of the global transient, whereas in juvenile rats it is reduced to ~20%. This developmental reduction indicates an important functional transition of the L-type Ca2+ channels from Ca2+ entry path to a predominantly Ca2+ trigger. Other sarcolemmal Ca2+ fluxes change with development as well. It is interesting that the mibefradil-sensitive T-type Ca2+ current practically no longer exists after 3 wk of age. This rapid disappearance of the T-type Ca2+ current coincides with the emergence of CICR mechanism of E-C coupling. Whether or not these two phenomena are related to each other we do not know, but an appealing possibility is that T-type channel could be more effective allowing Ca2+ entry to diffuse into the myoplasm than the L-type.


    ACKNOWLEDGMENTS
 
We are grateful to Dr. Philip M. Best for kindly providing mibefradil, to Dr. Tijani Gharbi for providing the nanogreen laser, and to Drs. N. Sarvazyan and R. Nathan for valuable comments.

GRANTS

This work was supported by Consejo Nacional de Ciencia y Tecnología Grant S1-95000493 and SEED grants (to A. L. Escobar) and by AmericanHeart Association Grant AHA-9950382N and National Heart, Lung, and Blood Institute Grant HL-62571-01 (to R. Mejía-Alvarez) R. Ribeiro-Costa was partially supported by a CAPES scholarship.


    FOOTNOTES
 

Address for reprint requests and other correspondence: R. Mejía-Alvarez, Dept. of Physiology, Loyola Univ. Chicago, 2160 S. First Ave., Maywood, IL 60153 (E-mail: rmejia{at}lumc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Development in Cardiovascular Medicine (1st ed.). Dordrecht, Boston, London: Kluwer Academic, 1991, vol. 122.
  2. Brown AM, Kunze DL, and Yatani A. Dual effects of dihydropyridines on whole cell and unitary calcium currents in single ventricular cells of guinea-pig. J Physiol 379: 495–514, 1986.[Abstract/Free Full Text]
  3. Cohen NM and Lederer WJ. Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol 406: 115–146, 1988.[Abstract/Free Full Text]
  4. Escobar AL, Monck JR, Fernandez JM, and Vergara JL. Localization of the site of Ca2+ release at the level of a single sarcomere in skeletal muscle fibres. Nature 367: 739–741, 1994.[CrossRef][Medline]
  5. Escobar AL, Ribeiro-Costa R, Villalba-Galea CA, Fill M, and Mejía-Alvarez R. Developmental changes of intracellular Ca2+ transients in beating rat hearts (Abstract). Biophys J 78: 98A, 2000.
  6. Escobar AL, Ribeiro-Costa R, Villalba-Galea CA, Manno C, Fernández LV, Trujillo EJ, Garbhi T, Fill M, and Mejía-Alvarez R. Pulsedlight, local-field fluorescence detection on intact mammalian heart (Abstract). Biophys J 78: 98A, 2000.
  7. Gomez JP, Potreau D, Branka JE, and Raymond G. Developmental changes in Ca2+ currents from newborn rat cardiomyocytes in primary culture. Pflügers Arch 428: 241–249, 1994.[CrossRef][Web of Science][Medline]
  8. Gorza Vettore LS, Tessaro A, Sorrentino V, and Vitadello M. Regional and age-related differences in mRNA composition of intracellular Ca(2+)-release channels of rat cardiac myocytes. J Mol Cell Cardiol 29: 1023–1036, 1997.[CrossRef][Web of Science][Medline]
  9. Haddock PS, Coetzee WA, Cho E, Porter L, Katoh H, Bers DM, Jafri MS, and Artman M. Subcellular [Ca2+]i gradients during excitation-contraction coupling in newborn rabbit ventricular myocytes. Circ Res 85: 415–427, 1999.[Abstract/Free Full Text]
  10. Hinde AK, Perchenet L, Hobai IA, Levi AJ, and Hancox JC. Inhibition of Na/Ca exchange by external Ni in guinea-pig ventricular myoyctes at 37°C, dialysed internally with cAMP-free and cAMP-containing solutions. Cell Calcium 25: 321–331, 1999.[CrossRef][Web of Science][Medline]
  11. Hobai IA, Hancox JC, and Levi AJ. Inhibition by nickel of the L-type Ca channel in guinea pig ventricular myocytes and effect of internal cAMP. Am J Physiol Heart Circ Physiol 279: H692–H701, 2000.[Abstract/Free Full Text]
  12. Husse B and Wussling M. Developmental changes of calcium transients and contractility during the cultivation of rat neonatal cardiomyocytes. Mol Cell Biochem 163–164: 13–21, 1996.
  13. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, and Nargeot J. T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol 279: H2540–H2548, 2000.[Abstract/Free Full Text]
  14. Lipp P and Niggli E. Modulation of Ca2+ release in cultured neonatal rat cardiac myocytes. Insight from subcellular release patterns revealed by confocal microscopy. Circ Res 74: 979–990, 1994.[Abstract/Free Full Text]
  15. Mejía-Alvarez R, Manno C, Villalba-Galea CA, Fernández LV, Ribeiro-Costa R, Fill M, Gharbi T, and Escobar AL. Pulsed local-field fluorescence microscopy: a new approach for measuring cellular signals in the beating heart. Pflügers Arch 445: 747–758, 2003.[Web of Science][Medline]
  16. Ost'ádalová I, Kolár F, and Ost'ádal B. Inotropic effect of low extra-cellular sodium on perfused perinatal rat heart. Can J Physiol Pharmacol 73: 50–54, 1995.[Web of Science][Medline]
  17. Page E and Buecker JL. Development of dyadic junctional complexes between sarcoplasmic reticulum and plasmalemma in rabbit left ventricular myocardial cells. Morphometric analysis. Circ Res 48: 519–522, 1981.[Abstract/Free Full Text]
  18. Page E, Earley J, and Power B. Normal growth of ultrastructures in rat left ventricular myocardial cells. Circ Res 35, Suppl II: 12–16, 1974.
  19. Pérez CG, Mejía-Alvarez R, and Escobar A. Temperature and frequency dependence of mouse cardiac activity during development (Abstract). Biophys J 84: 2110a, 2003.
  20. Rubenstein DS and Lipsius SL. Mechanisms of automaticity in subsidiary pacemakers from cat right atrium. Circ Res 64: 648–657, 1989.[Abstract/Free Full Text]
  21. Sedarat F, Xu L, Moore EDW, and Tibbits GF. Colocalization of dihydropyridine and ryanodine receptors in neonate rabbit heart using confocal microscopy. Am J Physiol Heart Circ Physiol 279: H202–H209, 2000.[Abstract/Free Full Text]
  22. Snopko RM, Karko KL, and Mejía-Alvarez R. In cardiac development, are culture days equivalent to postnatal days? Biophys J 84: 2108a, 2003.
  23. Snopko RM, Li Y, Pérez CG, Fan J, Halbach MD, Bers DM, Blatter LA, and Mejía-Alvarez R. Cell culture modifies the functional role of ryanodine receptors in neonate cardiac myocytes (Abstract). Biophys J 82: 69a, 2002.
  24. Studer R, Reinecke H, Vetter R, Holtz J, and Drexler H. Expression and function of the cardiac Na+/Ca2+ exchanger in postnatal development of the rat, in experimental-induced cardiac hypertrophy and in the failing human heart. Basic Res Cardiol 92, Suppl 1: 53–58, 1997.
  25. Tanaka H and Shigenoby K. Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J Mol Cell Cardiol 21: 1305–1313, 1989.[CrossRef][Web of Science][Medline]
  26. Tohse N, Masuda H, and Sperelakis N. Novel isoform of Ca2+ channel in rat fetal cardiomyocytes. J Physiol 451: 295–306, 1992.[Abstract/Free Full Text]
  27. Vornanen M. Contribution of sarcolemmal calcium current to total cellular calcium in postnatally developing rat heart. Cardiovasc Res 32: 400–410, 1996.[Abstract/Free Full Text]
  28. Wibo M, Bravo G, and Godfraind T. Postnatal maturation of excitation contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropiridine and ryanodine receptors. Circ Res 68: 662–673, 1991.[Abstract/Free Full Text]
  29. Xu X and Best PM. Postnatal changes in T-type calcium current density in rat atrial myocytes. J Physiol 454: 657–672, 1992.[Abstract/Free Full Text]
  30. Zhou Z and Lipsius SL. Na+-Ca2+ exchange current in latent pacemaker cells isolated from cat right atrium. J Physiol 466: 263–285, 1993.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
J. Mu, D. Qu, A. Bartczak, M. J. Phillips, J. Manuel, W. He, C. Koscik, M. Mendicino, L. Zhang, D. A. Clark, et al.
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice
Physiol Genomics, September 11, 2007; 31(1): 53 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Kapur and K. Banach
Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes
J. Physiol., June 15, 2007; 581(3): 1113 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. G. Perez, J. A. Copello, Y. Li, K. L. Karko, L. Gomez, J. Ramos-Franco, M. Fill, A. L. Escobar, and R. Mejia-Alvarez
Ryanodine receptor function in newborn rat heart
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2527 - H2540.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
286/3/H971    most recent
00308.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escobar, A. L.
Right arrow Articles by Mejía-Alvarez, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escobar, A. L.
Right arrow Articles by Mejía-Alvarez, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.